ABVC BioPharma, Inc. Proceeds from Common Stock Issued
ABVC BioPharma, Inc. (ECOC) reported Proceeds from Common Stock Issued of $131.04 thousand for the 6-month period ending 2024-06-30, per its 10-Q filed 2024-08-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2025-04-15
- ABVC BioPharma, Inc. proceeds from issuance of common stock for the quarter ending 2023-12-31 was $0.00.
- ABVC BioPharma, Inc. proceeds from issuance of common stock for the quarter ending 2022-12-31 was -$253.50K, a 105.97% decline year-over-year.
- ABVC BioPharma, Inc. proceeds from issuance of common stock for the quarter ending 2022-09-30 was $253.50K.
- ABVC BioPharma, Inc. proceeds from issuance of common stock for the quarter ending 2021-12-31 was $4.24M, a 22.29% decline year-over-year.
- ABVC BioPharma, Inc. proceeds from issuance of common stock for fiscal 2023 was $1.05M, a 71.34% decline from fiscal 2022.
- ABVC BioPharma, Inc. proceeds from issuance of common stock for fiscal 2022 was $3.66M, a 67.05% decline from fiscal 2021.
- ABVC BioPharma, Inc. proceeds from issuance of common stock for fiscal 2021 was $11.12M, a 46.01% increase from fiscal 2020.
- ABVC BioPharma, Inc. proceeds from issuance of common stock for fiscal 2020 was $7.62M, a 1333.75% increase from fiscal 2019.
| Period end | Proceeds from Issuance of Common Stock 2 month | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month |
|---|---|---|---|---|---|
| 2024-06-30 | $131.04K 10-Q · filed 2024-08-14 | ||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $1.05M 10-K · filed 2025-04-15 | |||
| 2023-09-30 | $1.05M 10-Q · filed 2024-11-14 | ||||
| 2022-12-31 | -$253.50K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $0.00 derived: sum of 2 quarters · filed 2024-03-13 | $3.66M 10-K · filed 2024-03-13 | ||
| 2022-09-30 | $253.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-15 | $3.92M 10-Q · filed 2023-11-15 | |||
| 2022-06-30 | $3.66M 10-Q · filed 2023-08-14 | ||||
| 2021-12-31 | $4.24M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $11.12M 10-K · filed 2023-03-31 | |||
| 2021-09-30 | $6.88M 10-Q · filed 2022-11-14 | ||||
| 2021-03-31 | $40.45K 10-Q · filed 2022-05-16 | $5.50M derived: sum of 2 quarters · filed 2022-05-16 | $5.96M derived: sum of 3 quarters · filed 2022-05-16 | $7.39M derived: sum of 4 quarters · filed 2022-05-16 | |
| 2020-12-31 | $5.46M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $5.92M derived: sum of 2 quarters · filed 2021-11-15 | $7.35M derived: sum of 3 quarters · filed 2021-11-15 | $7.62M 10-K · filed 2021-03-16 | |
| 2020-09-30 | $456.18K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $1.89M derived: sum of 2 quarters · filed 2021-11-15 | $2.15M 10-Q · filed 2021-11-15 | $2.15M derived: sum of 4 quarters · filed 2021-11-15 | |
| 2020-06-30 | $1.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $1.70M 10-Q · filed 2021-08-12 | $1.70M derived: sum of 3 quarters · filed 2021-08-12 | $1.70M derived: sum of 4 quarters · filed 2021-08-12 | |
| 2020-03-31 | $267.74K 10-Q · filed 2021-05-10 | $267.74K derived: sum of 2 quarters · filed 2021-05-10 | $267.74K derived: sum of 3 quarters · filed 2021-05-10 | $267.74K derived: sum of 4 quarters · filed 2021-05-10 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-15 | $0.00 derived: sum of 2 quarters · filed 2020-11-17 | $0.00 derived: sum of 3 quarters · filed 2020-11-17 | $531.15K 10-K · filed 2020-05-15 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-17 | $0.00 derived: sum of 2 quarters · filed 2020-11-17 | $531.15K 10-Q · filed 2020-11-17 | ||
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $531.15K 10-Q · filed 2020-08-14 | |||
| 2019-03-31 | $531.15K 10-Q · filed 2020-06-29 | ||||
| 2016-09-30 | $1.45M derived: 10-KT 12 month − 10-Q 9 month · filed 2018-04-13 | $2.35M 10-KT · filed 2018-04-13 | |||
| 2016-06-30 | $897.52K 10-Q · filed 2016-08-15 | ||||
| 2015-09-30 | $948.96K 10-K/A · filed 2017-09-22 |